[English] 日本語
Yorodumi
- PDB-6os0: Structure of synthetic nanobody-stabilized angiotensin II type 1 ... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 6os0
TitleStructure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II
Components
  • Angiotensinogen
  • Nanobody Nb.AT110i1
  • Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein
KeywordsMEMBRANE PROTEIN / GPCR / nanobody
Function / homology
Function and homology information


angiotensin type I receptor activity / regulation of blood volume by renin-angiotensin / angiotensin type II receptor activity / response to muscle activity involved in regulation of muscle adaptation / type 2 angiotensin receptor binding / negative regulation of neurotrophin TRK receptor signaling pathway / phospholipase C-activating angiotensin-activated signaling pathway / regulation of renal sodium excretion / G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger / maintenance of blood vessel diameter homeostasis by renin-angiotensin ...angiotensin type I receptor activity / regulation of blood volume by renin-angiotensin / angiotensin type II receptor activity / response to muscle activity involved in regulation of muscle adaptation / type 2 angiotensin receptor binding / negative regulation of neurotrophin TRK receptor signaling pathway / phospholipase C-activating angiotensin-activated signaling pathway / regulation of renal sodium excretion / G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger / maintenance of blood vessel diameter homeostasis by renin-angiotensin / regulation of extracellular matrix assembly / bradykinin receptor binding / regulation of renal output by angiotensin / positive regulation of extracellular matrix assembly / renin-angiotensin regulation of aldosterone production / renal system process / positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis / positive regulation of branching involved in ureteric bud morphogenesis / vasoconstriction / positive regulation of cholesterol metabolic process / type 1 angiotensin receptor binding / response to angiotensin / low-density lipoprotein particle remodeling / positive regulation of macrophage derived foam cell differentiation / positive regulation of extrinsic apoptotic signaling pathway / positive regulation of epidermal growth factor receptor signaling pathway / positive regulation of cardiac muscle hypertrophy / negative regulation of MAP kinase activity / positive regulation of gap junction assembly / regulation of systemic arterial blood pressure by renin-angiotensin / blood vessel remodeling / regulation of cardiac conduction / regulation of vasoconstriction / positive regulation of epithelial to mesenchymal transition / Metabolism of Angiotensinogen to Angiotensins / nitric oxide-cGMP-mediated signaling / Rho protein signal transduction / positive regulation of endothelial cell migration / Peptide ligand-binding receptors / blood vessel diameter maintenance / positive regulation of cytokine production / angiotensin-activated signaling pathway / cell chemotaxis / growth factor activity / regulation of cell growth / kidney development / serine-type endopeptidase inhibitor activity / calcium-mediated signaling / PPARA activates gene expression / electron transport chain / hormone activity / positive regulation of miRNA transcription / regulation of blood pressure / positive regulation of reactive oxygen species metabolic process / positive regulation of fibroblast proliferation / positive regulation of inflammatory response / Cargo recognition for clathrin-mediated endocytosis / cell-cell signaling / regulation of cell population proliferation / Clathrin-mediated endocytosis / : / positive regulation of cytosolic calcium ion concentration / regulation of inflammatory response / regulation of apoptotic process / G alpha (i) signalling events / blood microparticle / phospholipase C-activating G protein-coupled receptor signaling pathway / G alpha (q) signalling events / periplasmic space / electron transfer activity / positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction / G protein-coupled receptor signaling pathway / iron ion binding / inflammatory response / protein heterodimerization activity / heme binding / symbiont entry into host cell / positive regulation of DNA-templated transcription / extracellular space / extracellular exosome / extracellular region / membrane / plasma membrane
Similarity search - Function
Angiotensin II receptor type 1 / Angiotensinogen, serpin domain / Angiotensinogen / Angiotensin II receptor family / Cytochrome c/b562 / Serpin, conserved site / Serpins signature. / : / Serpin superfamily, domain 2 / Serpin family ...Angiotensin II receptor type 1 / Angiotensinogen, serpin domain / Angiotensinogen / Angiotensin II receptor family / Cytochrome c/b562 / Serpin, conserved site / Serpins signature. / : / Serpin superfamily, domain 2 / Serpin family / Serpin domain / Serpin superfamily / Serpin superfamily, domain 1 / Serpin (serine protease inhibitor) / SERine Proteinase INhibitors / Cytochrome b562 / Cytochrome b562 / Cytochrome c/b562 / Serpentine type 7TM GPCR chemoreceptor Srsx / Four Helix Bundle (Hemerythrin (Met), subunit A) / G-protein coupled receptors family 1 signature. / G protein-coupled receptor, rhodopsin-like / GPCR, rhodopsin-like, 7TM / G-protein coupled receptors family 1 profile. / 7 transmembrane receptor (rhodopsin family) / Up-down Bundle / Mainly Alpha
Similarity search - Domain/homology
Angiotensinogen / Soluble cytochrome b562 / Type-1 angiotensin II receptor
Similarity search - Component
Biological speciesHomo sapiens (human)
Escherichia coli (E. coli)
synthetic construct (others)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / molecular replacement / Resolution: 2.9 Å
AuthorsWingler, L.M. / Staus, D.P. / Skiba, M.A. / McMahon, C. / Kleinhenz, A.L.W. / Lefkowitz, R.J. / Kruse, A.C.
Funding support United States, 4items
OrganizationGrant numberCountry
National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)R01HL16037 United States
National Institutes of Health/Office of the Director5DP5OD021345 United States
Other private United States
Howard Hughes Medical Institute (HHMI) United States
CitationJournal: Science / Year: 2020
Title: Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR.
Authors: Wingler, L.M. / Skiba, M.A. / McMahon, C. / Staus, D.P. / Kleinhenz, A.L.W. / Suomivuori, C.M. / Latorraca, N.R. / Dror, R.O. / Lefkowitz, R.J. / Kruse, A.C.
History
DepositionMay 1, 2019Deposition site: RCSB / Processing site: RCSB
Revision 1.0Feb 19, 2020Provider: repository / Type: Initial release
Revision 1.1Mar 4, 2020Group: Database references / Category: citation / citation_author
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_PubMed / _citation.title / _citation_author.identifier_ORCID / _citation_author.name
Revision 1.2Jul 29, 2020Group: Data collection / Derived calculations / Structure summary
Category: chem_comp / entity ...chem_comp / entity / pdbx_chem_comp_identifier / pdbx_entity_nonpoly / struct_conn / struct_site / struct_site_gen
Item: _chem_comp.name / _entity.pdbx_description ..._chem_comp.name / _entity.pdbx_description / _pdbx_entity_nonpoly.name / _struct_conn.pdbx_role
Description: Carbohydrate remediation / Provider: repository / Type: Remediation
Revision 1.3Oct 11, 2023Group: Data collection / Database references ...Data collection / Database references / Refinement description / Structure summary
Category: chem_comp / chem_comp_atom ...chem_comp / chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model
Item: _chem_comp.pdbx_synonyms / _database_2.pdbx_DOI / _database_2.pdbx_database_accession
Revision 1.4Nov 20, 2024Group: Structure summary / Category: pdbx_entry_details / pdbx_modification_feature

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein
D: Nanobody Nb.AT110i1
B: Angiotensinogen
hetero molecules


Theoretical massNumber of molelcules
Total (without water)63,5676
Polymers63,2753
Non-polymers2923
Water32418
1


  • Idetical with deposited unit
  • defined by author&software
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Buried area5550 Å2
ΔGint-51 kcal/mol
Surface area25120 Å2
MethodPISA
Unit cell
Length a, b, c (Å)135.530, 37.830, 111.920
Angle α, β, γ (deg.)90.000, 94.410, 90.000
Int Tables number5
Space group name H-MC121

-
Components

-
Protein / Antibody / Protein/peptide / Sugars , 4 types, 4 molecules ADB

#1: Protein Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein / AT1AR / AT1BR / Angiotensin II type-1 receptor / AT1 / Cytochrome b-562


Mass: 48514.918 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human), (gene. exp.) Escherichia coli (E. coli)
Gene: AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B, cybC / Plasmid: pcDNA-Zeo-tetO / Cell line (production host): Expi293 / Production host: Homo sapiens (human) / References: UniProt: P30556, UniProt: P0ABE7
#2: Antibody Nanobody Nb.AT110i1


Mass: 13711.979 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) synthetic construct (others) / Production host: Escherichia coli BL21(DE3) (bacteria) / Variant (production host): BL21(DE3)
#3: Protein/peptide Angiotensinogen / Serpin A8


Mass: 1048.195 Da / Num. of mol.: 1 / Fragment: residues 34-41 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human) / References: UniProt: P01019
#4: Sugar ChemComp-NAG / 2-acetamido-2-deoxy-beta-D-glucopyranose / N-acetyl-beta-D-glucosamine / 2-acetamido-2-deoxy-beta-D-glucose / 2-acetamido-2-deoxy-D-glucose / 2-acetamido-2-deoxy-glucose / N-ACETYL-D-GLUCOSAMINE


Type: D-saccharide, beta linking / Mass: 221.208 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Formula: C8H15NO6
IdentifierTypeProgram
DGlcpNAcbCONDENSED IUPAC CARBOHYDRATE SYMBOLGMML 1.0
N-acetyl-b-D-glucopyranosamineCOMMON NAMEGMML 1.0
b-D-GlcpNAcIUPAC CARBOHYDRATE SYMBOLPDB-CARE 1.0
GlcNAcSNFG CARBOHYDRATE SYMBOLGMML 1.0

-
Non-polymers , 2 types, 20 molecules

#5: Chemical ChemComp-CL / CHLORIDE ION


Mass: 35.453 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: Cl
#6: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 18 / Source method: isolated from a natural source / Formula: H2O

-
Details

Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.26 Å3/Da / Density % sol: 45.59 %
Crystal growTemperature: 293 K / Method: lipidic cubic phase / pH: 7.6
Details: Protein complex was reconstituted with a 10:1 (w/w) mixture of monoolein and cholesterol. Crystals were grown in 100 mM Tris pH 7.6, 10 mM MgCl2, 25-26% PEG 300

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 23-ID-B / Wavelength: 1.033 Å
DetectorType: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Jun 29, 2018
RadiationMonochromator: Double Crystal / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.033 Å / Relative weight: 1
ReflectionResolution: 2.9→37.196 Å / Num. obs: 11842 / % possible obs: 91.2 % / Redundancy: 2.349 % / Biso Wilson estimate: 65.057 Å2 / CC1/2: 0.926 / Rmerge(I) obs: 0.276 / Rrim(I) all: 0.341 / Χ2: 0.961 / Net I/σ(I): 2.25 / Num. measured all: 27811 / Scaling rejects: 7
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsMean I/σ(I) obsNum. measured obsNum. possibleNum. unique obsCC1/2Rrim(I) all% possible all
2.9-2.982.3730.8060.6120369228580.3541.00293.1
2.98-3.062.4090.70.7521279398830.4210.86994
3.06-3.152.3430.6340.8919319118240.5270.78990.5
3.15-3.242.3120.5530.9918438477970.5760.68894.1
3.24-3.352.2580.5211.117708487840.5190.65192.5
3.35-3.472.3120.4851.4817438427540.6290.59689.5
3.47-3.62.3380.4421.7916347616990.7070.54991.9
3.6-3.742.420.409217307877150.7430.50790.9
3.74-3.912.4180.3972.3216327276750.6540.48892.8
3.91-4.12.3690.3722.6515427006510.7160.46393
4.1-4.322.370.3493.0114486736110.6930.43190.8
4.32-4.592.4170.2843.4713686345660.8360.34989.3
4.59-4.92.2440.2313.7212035985360.9090.28489.6
4.9-5.292.2990.2313.7111545635020.8760.28689.2
5.29-5.82.4390.2483.6511565114740.860.30292.8
5.8-6.482.4470.2233.810354834230.8780.27787.6
6.48-7.492.260.2024.088704263850.8780.25390.4
7.49-9.172.190.1484.557163583270.950.18391.3
9.17-12.972.3390.1285.185522832360.9660.15683.4
12.97-37.1962.2610.0975.133211731420.990.12582.1

-
Phasing

PhasingMethod: molecular replacement

-
Processing

Software
NameVersionClassificationNB
PHENIX(1.14_3260)refinement
XDSdata reduction
XSCALEdata scaling
PHASERphasing
PDB_EXTRACT3.25data extraction
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 6DO1

6do1


Resolution: 2.9→37.196 Å / SU ML: 0.55 / Cross valid method: THROUGHOUT / σ(F): 1.34 / Phase error: 35.6 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.318 1172 9.94 %
Rwork0.2593 10622 -
obs0.2652 11794 90.88 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso max: 178.82 Å2 / Biso mean: 79.6207 Å2 / Biso min: 36.06 Å2
Refinement stepCycle: final / Resolution: 2.9→37.196 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms4105 0 16 18 4139
Biso mean--120.21 61.8 -
Num. residues----529
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 8

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkNum. reflection all% reflection obs (%)
2.9-3.0320.40421340.34741324145892
3.032-3.19170.38161580.33091297145591
3.1917-3.39160.40461490.31471336148592
3.3916-3.65330.34241420.29821312145491
3.6533-4.02050.34081470.26211338148592
4.0205-4.60140.29411480.2281310145890
4.6014-5.79370.33441420.23671338148090
5.7937-37.19950.25011520.23131367151988

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more